OTCMKTS:BAYRY - Bayer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$29.20 -1.70 (-5.50 %)
(As of 06/21/2018 01:08 AM ET)
Previous Close$30.90
Today's Range$29.09 - $29.37
52-Week Range$27.60 - $35.41
Volume761,821 shs
Average Volume403,186 shs
Market Capitalization$103.70 billion
P/E Ratio15.37
Dividend Yield1.81%
Beta1.18
Bayer logoBayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BAYRY
CUSIPN/A
Phone49-21-4-30-1

Debt

Debt-to-Equity Ratio0.32
Current Ratio2.53
Quick Ratio2.04

Price-To-Earnings

Trailing P/E Ratio15.37
Forward P/E Ratio14.53
P/E Growth2.4

Sales & Book Value

Annual Sales$39.55 billion
Price / Sales2.44
Cash Flow$2.4767 per share
Price / Cash11.79
Book Value$12.60 per share
Price / Book2.32

Profitability

EPS (Most Recent Fiscal Year)$1.90
Net Income$8.29 billion
Net Margins11.96%
Return on Equity17.97%
Return on Assets7.87%

Miscellaneous

Employees115,200
Outstanding Shares3,307,800,000

Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How often does Bayer pay dividends? What is the dividend yield for Bayer?

Bayer announced an annual dividend on Monday, March 19th. Shareholders of record on Tuesday, May 29th will be paid a dividend of $0.614 per share on Monday, June 11th. The ex-dividend date is Friday, May 25th. View Bayer's Dividend History.

How were Bayer's earnings last quarter?

Bayer AG (OTCMKTS:BAYRY) announced its quarterly earnings data on Thursday, October, 29th. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.23. The firm had revenue of $12.28 billion for the quarter, compared to analysts' expectations of $12.79 billion. Bayer had a return on equity of 17.97% and a net margin of 11.96%. View Bayer's Earnings History.

When is Bayer's next earnings date?

Bayer is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Bayer.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Johannes M. Dietsch, Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board (Age 56)
  • Mr. Liam Condon, CEO & Pres of Bayer Cropscience and Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)

Has Bayer been receiving favorable news coverage?

Media headlines about BAYRY stock have trended positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bayer earned a daily sentiment score of 0.34 on Accern's scale. They also assigned headlines about the company an impact score of 45.44 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Bayer?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer's stock price today?

One share of BAYRY stock can currently be purchased for approximately $29.20.

How big of a company is Bayer?

Bayer has a market capitalization of $103.70 billion and generates $39.55 billion in revenue each year. The company earns $8.29 billion in net income (profit) each year or $1.90 on an earnings per share basis. Bayer employs 115,200 workers across the globe.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]


MarketBeat Community Rating for Bayer (BAYRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  207 (Vote Outperform)
Underperform Votes:  262 (Vote Underperform)
Total Votes:  469
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.